Grant Award Details

A COMPASS to guide the growth of a diverse regenerative medicine workforce that represents California and benefits the world
Grant Number: 
Project Objective: 
  • This COMPASS program at CalPoly SLO will train 25 COMPASS students to complete a 2-year program during the award duration. In the junior year, trainees will take two Cell Therapy lecture/lab courses to educate them in regenerative medicine topics and hands-on skills, while also taking a course on diversity in science and receiving mentoring and support from faculty, peers, industry members, and alumni. Trainees will complete a 3-month summer internship with one of our industry partners, with the option to extend to a 6-mo summer-fall ‘co-op’ or to complete an additional 3-mo internship the following year. Upon returning to campus for the senior year, students will perform research with a faculty mentor and complete a capstone project. The program will also provide participation in patient engagement and outreach activities.
Award Value: 

Grant Application Details

Application Title: 
  • A COMPASS to guide the growth of a diverse regenerative medicine workforce that represents California and benefits the world
Public Abstract: 
Statement of Benefit to California: 

Our COMPASS Scholars Program will provide numerous benefits to the state of California and its citizens.

First, approximately 25 Scholars, who may not have otherwise had the resources or “cultural capital” to attend or thrive at our university, will receive the finances and support necessary to enroll in our program, where they will complete courses, industry internships, and research projects with the support of a comprehensive mentoring program that will launch them into successful careers in regenerative medicine. This will increase opportunities for talented students from our state who come from underrepresented populations, and/or who have historically faced barriers to inclusion.

Second, hundreds of other students will benefit from the recruitment procedures, outreach, mentoring processes, coursework, and/or industry partnerships that we develop for the COMPASS Scholars Program, as we intend to broadly implement our best practices where appropriate. If other institutions choose to implement our best practices, based on the journal articles that we publish on those practices, then the beneficiaries of our approach could extend into the thousands of students each year.

Third, biotech companies will see their products advance more efficiently toward commercial implementation through the efforts of uniquely trained COMPASS Scholars and their classmates, as our graduates leverage our novel training program to make immediate impacts in their professional careers. These companies will also benefit from having more diverse perspectives and backgrounds within their workforce.

Fourth, all Californians will benefit from the availability of regenerative medicines that our COMPASS Scholars will help deliver sooner and more universally than they otherwise would be.